EFTA02521242
EFTA02521243 DataSet-11
EFTA02521245

EFTA02521243.pdf

DataSet-11 2 pages 340 words document
P17 V16 P24 V11 D4
Open PDF directly ↗ View extracted text
👁 1 💬 0
📄 Extracted Text (340 words)
From: Nathan Wolfe Sent: Wednesday, April 17, 2013 8:04 PM To: Jeffrey Epstein Subject: Fwd: Jeffrey Below are some references that show how sexual behavior questionnaires have been validated. I believe these issues have been well addressed and am not concerned that we can get good data on changes in sexual behavior within individuals over time in relation to variables like the incidence of new STIs Nathan Forwarded From: Karen Saylors Date: Wed, Apr 17, 2013 at 12:55 PM Subject: Re: To: Nathan Wolf Cc: Kasey Kissick The test-retest approach with a strong sexual behavior scale seems like the best way to screen: 1) Test-retest reliability and predictors of unreliable reporting for a sexual behavior questionnaire for U.S. men. chttp://www.ncbi.nlm.nih.gov/pubmed/19705273> 2) Test-retest reliability of self-reported HIV/STD-related measures among African-American adolescents in four U.S. cities. <http://www.ncbi.nlm.nih.gov/pubmed/19237106> Another approach is interpartner reliability/comparison, which would lead us in the direction of partner contact tracing: 3) Reliability of self-reported sexual histories: test-retest and interpartner comparison in a sexually transmitted diseases clinic. <http://www.ncbi.nlm.nih.gov/pubmed/9918321> 4) Interpartner reliability of reporting of recent sexual behaviors. <http://www.ncbi.nlm.nih.gov/pubmed/1746526> There are lots of standardized instruments on sexual behavior and STI transmission, including the National Survey of Family Growth and General Social Survey: EFTA_R1_01658368 EFTA02521243 5) Sexual partnership patterns as a behavioral risk factor for sexually transmitted diseases. <http://www.ncbi.nlm.nih.gov/pubmed/10723647> If we proceed with a cohort study, we can think further on how we would structure that. Thanks, Karen On 4/17/13 12:13 PM, "Nathan Wolfe' wrote: >http://www.ncbi.nlm.nih.gov/pubmed?LinkName=pubmed_pubmed&from_uid=1970 >527 >3 >Dr. Nathan Wolfe I Founder and CEO I Metabiota >Email Office: >metabio a.com >Please note that Global Viral Forecasting Inc. (GVF Inc.) has changed >its name to Metabiota and Global Viral Forecasting Initiative (GVFI) is >now known as Global Viral. For more details, please see our >websites: metabiota.com and globalviral.org. For information on my >teaching and public engagement please see nathanwolfe.net. <?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE plist PUBLIC "-//Apple//DTD PLIST 1.0//EN" "http://www.apple.com/DTDs/PropertyList-1.O.dtd"> <plist version="1.0"> <dict> <key>conversation-idgkey> <integer>139166</integer> <key>date-last-viewed</key> <integer>0</integer> <key>date-received</key> <integer>1366229036</integer> <key>flags</key> <integer>8590195713</integer> <key>gmail-label-ids</key> <array> <integer>6</integer> <integer>2</integer> </array> <key>remote-id</key> <string>292403</string> </dict> </plist> 2 EFTA_R1_01658369 EFTA02521244
ℹ️ Document Details
SHA-256
55ca3965afab677ebdd6159819f664052e215daec21cb8cc236a5b318a4405ad
Bates Number
EFTA02521243
Dataset
DataSet-11
Document Type
document
Pages
2

Comments 0

Loading comments…
Link copied!